 |
 President, Chief Executive Officer, Chief Financial Officer, General Counsel, Treasurer and Director Mr. Desjourdy has served as Chief Executive Officer of the Company since June 2005, President and General Counsel of the Company since December 1999, Chief Financial Officer since September 1993, and Treasurer from May 1994. Prior to that time, he held the titles of Chief Operating Officer of the Company from December 1999 to June 2005, Executive Vice President of the Company from July 1996 to December 1999, and Vice-President - Finance and Administration of the Company from September 1993 to July 1996. From September 1989 to September 1993, Mr. Desjourdy was an attorney at the law firm of Choate Hall & Stewart. From September 1983 to September 1986, Mr. Desjourdy was a certified public accountant at Arthur Andersen & Co. Mr. Desjourdy holds a J.D. from Boston College and a Master of Finance from Bentley College. |
| Members of the Board of Directors
Eugene Lieberstein Mr. Lieberstein is a partner at the law firm of Anderson Kill & Olick, P.C. specializing in patent procurement and litigation since March 2000. Mr. Lieberstein was a partner at the law firm of Wyatt, Gerber, Meller and O’Rourke specializing in patent procurement and litigation from 1993 to March 2000. He was patent counsel for Union Carbide Corporation from 1970 to 1993. James C. Richards, Ph.D. Dr. Richards is the President, Chief Executive Officer and director of EdgeLight Bioscience, Inc., a privately held company specializing in wave-guide diagnostic life science applications, since March 2000. Dr. Richards was the President, Chief Executive Officer and a director of IntelliGene, Inc., a privately held company specializing in DNA probe technologies from October 1995 to March 2000. He was the President and Chief Executive Officer of Symbollon from May 1991 to September 1995 and Treasurer of Symbollon from May 1991 to May 1994. Dr. Richards was the Managing Director and principal stockholder of Carlton Bio Venture Partners, a consulting firm specializing in financing and acquisition of healthcare, medical products and biotechnology companies from 1990 to 1991. Prior to that time, he served as the Director of business planning and development for Gene-Trak Systems, a joint venture originally between AMOCO Corporation and Integrated Genetics, Inc., engaged in developing diagnostic test devices using DNA probes for the healthcare and food industries, from 1986 to 1990. Richard F. Maradie Mr. Maradie is retired. He was the Senior Vice President of Commercial Development of Oakwood Laboratories, a private biopharmaceutical company developing drug delivery technologies, from April 1998 to September 2000. Mr. Maradie was the President, Chief Executive Officer and a director of Novavax, Inc., a public biopharmaceutical company developing topical and oral drug delivery technologies, from March 1997 to August 1998. He was the President, Chief Executive Officer and a director of Protyde Pharmaceuticals, Inc., a private biopharmaceutical company developing products for the diagnosis and treatment of cancer, from 1994 to 1997. Prior to that time, he was the Executive Vice President and Chief Operating Officer of Platelet Research Products, Inc., a private biopharmaceutical company developing therapeutic products derived from blood platelets, from to 1991 to 1994. Mr. Maradie had served as the President, Chief Operating Officer and a director of VimRx Pharmaceuticals, Inc., a public pharmaceutical company developing therapeutics based on natural products, from 1988 to 1991. Jack H. Kessler, Ph.D. Dr. Kessler was the founder of the Company and he has held the following titles served while employed at the Company: Chief Executive Officer from December 1999 to June 2005; Chief Scientific Officer and Secretary from May 1991 to June 2008; and Executive Vice-President of the Company from May 1991 to December 1999; and from the Company's formation in Illinois in 1986 until 1991 Dr Kessler was the Company's sole stockholder and served as its sole officer and director. Dr. Kessler has served as a director since May 1991 and as Chairman of the Board of Directors since May 1996. From January 1990 until May 1991, he served as principal systems engineer for Kollsman Manufacturing Company, a diagnostic instrument design and manufacturing company. Prior to January 1990, he worked at Gene-Trak Systems as a manager of engineering applications, and at the New Technologies Group within the Diagnostic Division of Hoffman-LaRoche. Dr. Kessler received a B.S. in Chemistry from Stevens Institute of Technology, and a Ph.D. from the State University of New York at Syracuse.
Mr. Desjourdy has served as President, Chief Operating Officer and General Counsel of the Company since December 1999, Chief Financial Officer since September 1993, and Treasurer from May 1994. Prior to that time, he held the titles of Executive Vice President of the Company from July 1996 to December 1999, and Vice-President - Finance and Administration of the Company from September 1993 to July 1996. From September 1989 to September 1993, Mr. Desjourdy was an attorney at the law firm of Choate Hall & Stewart. From September 1983 to September 1986, Mr. Desjourdy was a certified public accountant at Arthur Andersen & Co. Mr. Desjourdy holds a J.D. from Boston College and a Master of Finance from Bentley College.
|
